A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3) : trial protocol
Citation
May , J , Duncan , C , Mol , B , Bhattacharya , S , Daniels , J , Middleton , L , Hewitt , C , Coomarasamy , A , Jurkovic , D , Bourne , T , Bottomley , C , Peace-Gadsby , A , Doust , A , Tong , S & Horne , A W 2018 , ' A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3) : trial protocol ' , Trials , vol. 19 , 643 . https://doi.org/10.1186/s13063-018-3008-6
Rights
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.